Harvard Bioscience, Inc. (FRA:HBI)
0.4340
-0.0340 (-7.26%)
At close: Jan 30, 2026
Harvard Bioscience Market Cap
Harvard Bioscience has a market cap or net worth of €18.85 million as of January 30, 2026. Its market cap has decreased by -77.54% in one year.
Market Cap
18.85M
Enterprise Value
49.13M
Revenue
74.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.43
Market Cap Chart
Since December 7, 2000, Harvard Bioscience's market cap has decreased from 218.76M to 18.85M, a decrease of -91.38%. That is a compound annual growth rate of -9.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 18.85M | -25.75% |
| Dec 31, 2025 | 25.39M | -71.43% |
| Dec 31, 2024 | 88.89M | -56.98% |
| Dec 29, 2023 | 206.62M | 91.36% |
| Dec 30, 2022 | 107.97M | -57.32% |
| Dec 31, 2021 | 252.99M | 85.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |
| ACCENTRO Real Estate AG | 21.00M |
| Petro Matad | 20.45M |
| Pearl Gold AG | 19.25M |
| tick Trading Software AG | 16.61M |
| AdCapital AG | 16.03M |
| Pasinex Resources | 15.72M |
| Consensus Asset Management AB | 15.17M |